Interim Report to 30 September 2015 is now available to view via the following link. The PDF report will download automatically when clicked.
Access to AFT FY16 Interim Report
Similar articles
New VitA-Pos Eye Ointment Introduced for night time use
AFT Pharmaceuticals is pleased to announce the launch of the new VitA-POS® eye ointment to the Australian market.
Read more
AFT builds North American momentum
Diversified pharmaceutical company appoints new north American-based director and launches Maxigesic® in Canada.
Read more
AFT Pharmaceuticals Strengthens Asian Operations
AFT Pharmaceuticals (AFT) is continuing to build its business operations in South East Asia by moving to the appointment of a Business Manager based in its Kuala Lumpur office in Malaysia.
Read more